Hiki i ka hānai ʻana i ka ʻiʻo maka i nā ʻīlio ke hoʻolaha i nā maʻi maʻi weliweli

1.Ua hōʻike ʻia kahi noiʻi e pili ana i 600 mau ʻīlio pipi olakino i kahi pilina paʻa ma waena o ka hānai ʻana i ka ʻiʻo maka a me ka noho ʻana o E. coli i loko o nā feces o nā ʻīlio e kū kūʻē i ka ciprofloxacin antibiotic ākea.ʻO ia hoʻi, hiki ke hoʻolaha ʻia kēia bacteria weliweli a paʻakikī hoʻi i waena o nā kānaka a me nā holoholona mahiʻai ma o ka ʻiʻo maka i hānai ʻia i nā ʻīlio.He mea weliweli kēia ʻike a ua aʻo ʻia e kahi hui noiʻi ʻepekema mai ke Kulanui o Bristol ma UK.

2. ʻO Jordan Sealey, he genetic epidemiologist ma ke Kulanui o Bristol, i ʻōlelo: "ʻAʻole kā mākou manaʻo i ka ʻai ʻīlio maka ponoʻī, akā i nā mea e hiki ke hoʻonui i ka pilikia o nā ʻīlio e hoʻokahe i ka lāʻau E. coli i loko o kā lākou faeces."

Ua hōʻike nā hopena o ke aʻo ʻana i kahi hui ikaika ma waena o ka hānai ʻana i nā ʻīlio i ka meaʻai maka a me nā ʻīlio i hoʻokuʻu ʻia i ka ciprofloxacin-resistant E. coli.

ʻO ia hoʻi, ma ka hānai ʻana i ka ʻiʻo maka i nā ʻīlio, hiki iā ʻoe ke hoʻolaha i ka maʻi bacteria weliweli a paʻakikī hoʻi e pepehi i waena o nā kānaka a me nā holoholona mahiʻai.Ua hoʻopūhoihoi ka ʻike i nā mea noiʻi ma ke Kulanui o Bristol ma UK.

"ʻAʻole kā mākou noiʻi ʻana i ka meaʻai ʻīlio maka, akā i nā mea e hoʻonui ai i ka pilikia o nā ʻīlio e hoʻokuʻu i ka lāʻau E. coli i loko o kā lākou faeces," wahi a Jordan Sealey, he genetic epidemiologist ma ke Kulanui o Bristol.

3. "Ke hōʻike nei kā mākou hopena i kahi pilina ikaika loa ma waena o ka ʻiʻo maka i ʻai ʻia e nā ʻīlio a me kā lākou hoʻohemo ʻana i ka ciprofloxacin-resistant E. coli."

Ma muli o ka nānā ʻana i ka fecal a me nā nīnau nīnau mai nā mea nona nā ʻīlio, me kā lākou ʻai, nā hoa holoholona ʻē aʻe, a me ka hele wāwae a me ka pāʻani ʻana, ua ʻike ka hui ʻo ka ʻai ʻana i ka ʻiʻo maka wale nō kahi kumu nui no ka hemo ʻana o ka antibiotic-resistant E. coli.

ʻO ka mea ʻē aʻe, ua like ka maʻi E. coli maʻamau i nā ʻīlio kuaʻāina me nā mea i loaʻa i loko o nā pipi, ʻoiai ʻo nā ʻīlio ma nā kūlanakauhale ka mea i loaʻa i ka maʻi kanaka, e hōʻike ana i kahi ala paʻakikī o ka maʻi.

No laila, koi ikaika ka poʻe noiʻi i nā mea nona nā ʻīlio e noʻonoʻo i ka hāʻawi ʻana i kā lākou mau puaʻa me ka meaʻai meaʻai ʻole a koi aku i nā mea mālama holoholona e hana i nā hana e hōʻemi i ka hoʻohana ʻana i nā lāʻau lapaʻau ma kā lākou mau mahiʻai e hōʻemi i ka hopena o ka pale ʻana i ka lāʻau antibiotic.

Ua ʻōlelo pū ʻo Matthew Avison, he molecular bacteriologist ma ke Kulanui o Bristol: "Pono e kau ʻia nā palena paʻa i ka nui o nā hua bacteria i ʻae ʻia i ka ʻiʻo i hoʻomoʻa ʻole ʻia, ma mua o ka ʻiʻo i kuke ʻia ma mua o ka ʻai ʻana."

ʻO E. coli kekahi ʻāpana o ka microbiome ʻōpū olakino i loko o ke kanaka a me nā holoholona.ʻOiai ʻaʻole pōʻino ka hapa nui o nā maʻi, hiki i kekahi ke hoʻopilikia i nā pilikia, ʻoi aku hoʻi i nā poʻe me nā ʻōnaehana pale nāwaliwali.Ke loaʻa mai nā maʻi maʻi, ʻoi aku hoʻi i loko o nā ʻiʻo e like me ke koko, hiki iā lākou ke hoʻoweliweli i ke ola a koi aku i ka lāʻau ulia pōpilikia me nā lāʻau antibiotic.

Manaʻo ka hui noiʻi he mea koʻikoʻi ka hoʻomaopopo ʻana i ke ʻano o ke olakino o ke kanaka, nā holoholona a me ke kaiapuni i ka hoʻomalu maikaʻi ʻana a me ka mālama ʻana i nā maʻi i hoʻokumu ʻia e E. coli.